greeksoup/ stock research

Chemed (CHE) Q1 FY2025 earnings: revenue $647 million, up 9.8% on the year

Chemed Corp. (CHE) reported revenue of $647 million for Q1 FY2025, the quarter ended 31 March 2025, up 9.8% on the same quarter a year earlier. Net income was $72 million, up 10.4% on the year, and diluted earnings per share $4.86. The figures are the company's own, from the 10-Q it filed with the SEC on 28 April 2025.

Revenue$647 millionup 9.8%
Net income$72 millionup 10.4%
Diluted EPS$4.86
QuarterQ1 FY2025ended 31 March 2025

The quarter, against the one before and a year earlier

LineQ1 FY2025Q4 FY2024Q1 FY2024Change on the year
Revenue647640589+9.8%
Cost of revenue431406385+11.8%
Gross profit216234204+6.0%
Gross margin33.5%36.6%34.6%
Selling, general and administrative106104116-8.9%
Operating income94.811472.3+31.0%
Operating margin14.6%17.8%12.3%
Interest expense0.30.50.4-22.6%
Pre-tax income95.712084.5+13.2%
Income tax23.929.819.5+22.9%
Effective tax rate25.0%24.8%23.0%
Net income71.890.365.0+10.4%
Net margin11.1%14.1%11.0%
Diluted EPS$4.86$6.02$4.24+14.6%
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ1 FY2025Q4 FY2024Q1 FY2024Change on the year
Operating cash flow32.716584.5-61.3%
Capital expenditure13.312.812.2+9.2%
Free cash flow19.515272.4-73.1%
Free cash flow margin3.0%23.8%12.3%
Cash from investing-13.7-12.5-19.4n/a
Cash from financing-23.5-212-15.8n/a
Depreciation and amortisation16.015.815.8+1.3%
Buybacks33.220938.5-13.6%
Dividends paid7.37.56.0+21.1%
Dividend per share$0.50n/a$0.40+25.0%
Diluted shares, weighted15m15m15m-3.7%
Shares outstanding at period end15m15m15m-3.4%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ1 FY2025Q4 FY2024Q1 FY2024Change on the year
Shareholders' equity1,1821,1191,183-0.1%
Debtn/a0.0n/an/a
Operating lease liabilities10298.5107-4.5%
Other liabilities443451437+1.2%
Total liabilities and equity1,7271,6691,728-0.1%
Fixed assets200201203-1.5%
Goodwill667667592+12.8%
Intangible assets89.992.288.1+2.0%
Cash and equivalents174178313-44.5%
Receivables286171177+61.2%
Inventory7.88.210.7-27.3%
Other assets302351344-12.0%
Total assets1,7271,6691,728-0.1%

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue565586589596606640647619625639658673
Cost of revenue362358385390396406431434428414442452
Gross profit202228204206210234216185197225216221
Gross margin36%39%35%35%35%37%33%30%32%35%33%33%
SG&A99.6100116102102104106100106106114115
Operating income86.811172.388.192.211494.868.174.810184.689.2
Operating margin15%19%12%15%15%18%15%11%12%16%13%13%
Interest expense0.40.30.40.40.40.50.30.40.50.50.51.8
Pre-tax income93.311684.593.810112095.771.183.510588.891.3
Tax rate20%22%23%24%25%25%25%26%23%27%25%26%
Net income75.090.165.070.975.890.371.852.564.276.866.367.7
Net margin13%15%11%12%13%14%11%8%10%12%10%10%
Diluted EPS$4.93$5.90$4.24$4.65$5.00$6.02$4.86$3.57$4.46$5.48$4.84$5.13
Operating cash flow28.910984.577.590.516532.713983.413488.284.8
Capital expenditure11.711.812.296.418.612.813.315.817.516.317.115.5
Free cash flow17.396.872.4-18.971.915219.512365.911771.169.3
Buybacks14.3n/a38.555.857.820933.242.918117519097.5
Dividends paid6.06.16.06.17.57.57.37.28.78.58.27.9
Shares outstanding15m15m15m15m15m15m15m15m14m14m13m13m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 31 March 2025, filed 28 April 2025, accession 0001562762-25-000096: the filing on EDGAR. All of Chemed Corp.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install